Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 20

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 20
---
 in managing and operating a public company and required to devote          
 substantial time to compliance initiatives and reporting requirements associated therewith.        
 See more detailed discussion of this risk factor on page 44 of this prospectus.                    |

| ● | If                                                                                                 
 we fail to implement and maintain an effective system of internal controls, we may be unable       
 to accurately or timely report our results of operations or prevent fraud, and investor confidence 
 and the market price of our Class A Ordinary Shares may be materially and adversely affected.  See 
 more detailed discussion of this risk factor on page 45 of this prospectus.                        |

<div align='center'>7</div>

| ● | If                                                                                              
 we are listed on the Nasdaq Capital Market and our financial condition deteriorates, we may     
 not meet continued listing standards on the Nasdaq Capital Market. See more detailed discussion 
 of this risk factor on page 46 of this prospectus.                                              |

| ● | We                                                                                         
 have not finally determined the use of the proceeds from this offering, and we may use the 
 proceeds in ways with which you may not agree. See more detailed discussion of this risk   
 factor on page 46 of this prospectus.                                                      |

| ● | We                                                                                       
 may be classified as a passive foreign investment company, which could result in adverse 
 U.S. federal income tax consequences to U.S. Holders of our Class A Ordinary Shares. See 
 more detailed discussion of this risk factor on page 46 of this prospectus.              |

Corporate History and Holding Company Structure We are an exempted company incorporated with limited liability under the laws of the Cayman Islands on May 7, 2024 with operations conducted through primarily our Hong Kong subsidiary, Living Homeopathy Hong Kong. The Company was incorporated in connection with a reorganization for the proposed initial public offering. The Company has 50,000 authorized shares with a par value of $1 per share. On May 7, 2024, on its date of incorporation, the Company allotted and issued one share to LTO Holdings Ltd. (“LTO”), a BVI company controlled by Mr. To. On May 27, 2024, Living Homeopathy Global Limited (“Living Global”) was incorporated in BVI with limited liability and 50,000 authorized shares at $1 per share. On its date of incorporation, Living Global allotted and issued one share to the Company at $1. Upon completion of such allotment and issue of share of Living Global to the Company, Living Global became